Skip to content
ANDREESSEN HOROWITZ
It's time to build
Nav Opener
  • Portfolio
  • Team
  • Focus Areas
    • Bio
    • Cultural Leadership Fund
    • Consumer
    • Crypto
    • Enterprise
    • Fintech
    • Growth
    • Talent x Opportunity
  • Content
    Topics
    • Fintech
    • Gaming & Social
    • Security & Privacy
    • Marketplaces
    • Enterprise & SaaS
    • Bio
    • Consumer
    • Cryptocurrencies & Blockchains
    Type
    • Articles
    • Video
    • Podcasts
    • Newsletters
  • About
Close

Justin Larkin

Justin Larkin Follow LinkedIn

Justin Larkin is a partner on the Bio investing team, focusing primarily on health technology companies that are transforming the way patients, payors, and providers experience and deliver healthcare. 

Prior to joining a16z, Justin led the Strategy and Ops org at Verily (formerly known as Google Life Sciences), working across their portfolio of care delivery, software analytics, and med device business lines. Prior to that, Justin was a co-founder and the product / clinical lead at Wellsheet, a venture-backed health IT company focused on using ML to streamline physician workflows within electronic health records.

Justin holds an MD from the University of Pennsylvania where he was a John Morgan Scholar and a founding member of PennHealthX, an endowed program for cross-disciplinary training in clinical medicine and health technology / entrepreneurship. Justin also holds an MBA from the Stanford Graduate School of Business, as well as a BS / BA from BYU in Developmental Biology and Portuguese, respectively.

Latest Posts

Building Clinical Rigor into Virtual Care

by Justin Larkin
  • bio
  • building a bio company
  • care delivery
  • Company Building 101
  • digital health
  • healthcare

16 Minutes #47: Transparency in Pricing, Ruling Healthcare

by Julie Yoo, Justin Larkin, and Sonal Chokshi
  • bio
  • news
  • policy & regulation
  • 16 Minutes
  • healthcare

a16z Journal Club: Therapeutic Video Game on Trial

by Justin Larkin and Lauren Richardson
  • bio
  • gaming, social, and new media
  • a16z Journal Club
  • clinical trials
  • digital therapeutics

16 Minutes on the News #34: Videogames as Medicines — So What Is/Isn’t a Digital Drug?

by Nikhil Krishnan, Justin Larkin, Vijay Pande, and Sonal Chokshi
  • bio
  • gaming, social, and new media
  • news
  • policy & regulation
  • disruption theory & practice
  • 16 Minutes
  • digital therapeutics
  • healthcare

From @justin_larkinMD

Margit Wennmachers@wennmachers

When @a16z started in 2009, we embraced blogging to speak directly to our audience of builders and founders. We're expanding our content operation into its own media property to help make sense of technology, innovation, and the future. https://t.co/iZEjVxmzeE Here's why 👇

Andrew Chen@andrewchen

👇 Some news: I've led a16z's new investment in Clubhouse and have joined the board. Essay below that covers: - how I know founders @pdavison @rohanseth - why we're excited to invest - how we think Clubhouse is unique - particularly for creators! https://t.co/2t1Uzj2uJ4

Andy Tran@andy23tran

1/ Biotech platforms are rich product engines that can generate endless applications, multiple shots on goal. But...startup resources are finite. My @a16z partner @JorgeCondeBio and I describe how to find Product-Disease Fit to pick your best shot. 🎯 https://t.co/b2Zjnx7Nq7

Software is eating the world
© 2021 Andreessen Horowitz
Software is eating the world
    • Twitter
    • Simplecast
  • Contact
  • Jobs
  • Briefings
  • Terms of Use & Privacy
  • Disclosures
  • Conduct
  • Who We Are